Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Genetics|December 20, 2021
Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinibErin R Rudzinski, Jaclyn Hechtman, Sinchita Roy-Chowdhuri, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancerByoung Chul Cho, Grace K Dy, Ramaswamy Govindan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2013
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphomaMatthias Pfeifer, Michael Grau, Dido Lenze, et al.
Blood|July 23, 2013
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCLHendrik Nogai, Sören-Sebastian Wenzel, Stephan Hailfinger, et al.
British Journal of Cancer|May 3, 2017
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignanciesRastislav Bahleda, Juneko E Grilley-Olson, Ramaswamy Govindan, et al.
The Lancet. Oncology|August 14, 2019
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion studyMartin Schuler, Byoung Chul Cho, Cyrus Michael Sayehli, et al.
Pageof 2